HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia
- DOI
- 10.1002/14651858.cd014565
- Published
- 2025-09-19
- Container
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/14651858.cd014565,
title = {HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia},
author = {Yusuke Saishoji and Saehyeon Kim and Masahiro Banno and Kunihiro Kohmura and Yuki Kataoka and Yasushi Tsujimoto},
year = {2025},
journal = {Cochrane Database of Systematic Reviews},
doi = {10.1002/14651858.cd014565},
url = {https://doi.org/10.1002/14651858.cd014565}
}RIS
TY - JOUR TI - HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia AU - Yusuke Saishoji AU - Saehyeon Kim AU - Masahiro Banno AU - Kunihiro Kohmura AU - Yuki Kataoka AU - Yasushi Tsujimoto PY - 2025 JO - Cochrane Database of Systematic Reviews DO - 10.1002/14651858.cd014565 UR - https://doi.org/10.1002/14651858.cd014565 ER -
APA
Saishoji, Y., Kim, S., Banno, M., Kohmura, K., Kataoka, Y., & Tsujimoto, Y. (2025). HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd014565
Source records
- crossref · retrieved 2026-09-25T09:03:07.826Z